» Authors » Ryohei Nishimura

Ryohei Nishimura

Explore the profile of Ryohei Nishimura including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 140
Citations 868
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Takahashi Y, Kato D, Maeda S, Motegi T, Fujita A, Hashimoto Y, et al.
Can Vet J . 2025 Mar; 66(3):318-326. PMID: 40070938
Objective: This study aimed to evaluate outcomes and complications in dogs with urothelial carcinoma (UC) of the bladder trigone treated with total cystectomy using uretero-prepuce/vagina/cutaneous anastomosis combined with medical treatment....
2.
Muta K, Koizumi M, Miyabe-Nishiwaki T, Sotomaru Y, Nobukiyo A, Ohta H, et al.
J Med Primatol . 2025 Feb; 54(2):e70006. PMID: 39973069
Background: Common marmosets (Callithrix jacchus) have been widely used as laboratory animals; However, limited sedation and anesthetic protocols have yet to be established. In this study, the minimum alveolar concentration...
3.
Eto S, Kato D, Saeki K, Iguchi T, Shiyu Q, Kamoto S, et al.
Vet Comp Oncol . 2024 Aug; 22(4):500-512. PMID: 39179510
A comprehensive understanding of the tumour immune microenvironment (TIME) is essential for advancing precision medicine and identifying potential therapeutic targets. This study focused on canine urothelial carcinoma (cUC) recognised for...
4.
Kodera Y, Iguchi T, Kato D, Ikeda N, Shinada M, Aoki S, et al.
J Vet Med Sci . 2024 Jul; 86(9):961-965. PMID: 39034152
Canine urothelial carcinoma (cUC) is one of the most malignant tumors affecting dogs; however, its proliferative mechanism is yet to be fully elucidated. The ubiquitin-proteasome system (UPS) is an important...
5.
Fujita N, Sugiyama F, Tsuboi M, Nakamura H, Nishimura R, Nakayama Y, et al.
Bioengineering (Basel) . 2024 Jun; 11(6). PMID: 38927851
Urinary tract diseases are common in cats, and often require surgical reconstruction. Here, to explore the possibility of urinary tract reconstruction in cats using in-body tissue architecture (iBTA), biosheets fabricated...
6.
Eto S, Shinada M, Saeki K, Tsuboi M, Kamoto S, Yoshitake R, et al.
Vet J . 2024 Jan; 304:106064. PMID: 38242282
Cyclooxgenase-2 (COX-2) is associated with inflammatory microenvironment and tumour progression. COX-2 expression was reported in canine tumours, and anti-COX treatment showed therapeutic effects in selected tumour types. Currently, direct comparisons...
7.
Ishimaru K, Ikeda M, Miyamoto H, Furusawa S, Abe K, Watanabe M, et al.
J Am Heart Assoc . 2023 Dec; 13(1):e031219. PMID: 38158218
Background: Ferroptosis, an iron-dependent form of regulated cell death, is a major cell death mode in myocardial ischemia reperfusion (I/R) injury, along with mitochondrial permeability transition-driven necrosis, which is inhibited...
8.
Hashimoto Y, Nakagawa T, Nishimura R
Can J Vet Res . 2023 Oct; 87(4):282-289. PMID: 37790271
Little is known about the perioperative complications and treatment outcomes of repairing perineal hernias using semitendinosus muscle transposition (SMT) in small-breed dogs. The objective of this study was to retrospectively...
9.
Shinada M, Kato D, Tsuboi M, Ikeda N, Aoki S, Iguchi T, et al.
J Vet Med Sci . 2023 Aug; 85(10):1068-1073. PMID: 37544715
Podoplanin (PDPN) is a prognostic factor and is involved in several mechanisms of tumor progression in human squamous cell carcinoma (SCC). Canine non-tonsillar SCC (NTSCC) is a common oral tumor...
10.
Shinada M, Kato D, Motegi T, Tsuboi M, Ikeda N, Aoki S, et al.
Mol Cancer Res . 2023 Jul; 21(11):1205-1219. PMID: 37493578
Implications: Podoplanin could be a new therapeutic target to restrict the metastatic dissemination of canine and human mucosal melanoma.